Recent Updates
  • The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030

    Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
    The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030 Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions For additional details, please visit https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
    0 Comments 0 Shares
  • Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030

    Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
    Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030 Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.html
    Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing | Industry Analysis | Market Size | 2030
    The Novel Immuno-Oncology / Cancer Biomarker Testing market is anticipated to grow at an annualized rate of ~18% over the next decade
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%

    Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
    The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7% Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions For additional details, please visit https://www.rootsanalysis.com/reports/view_document/digital-health-market-focus-on-digital-therapeutic-monitoring-and-diag/208.html
    0 Comments 0 Shares
  • Despite of an exhaustive mechanism of DNA processing and its highly stable structure, DNA is bound to undergo damage by several factors


    DNA damage can be referred to as any adverse alteration, which may occur in the form of base additions, base deletions or break in the sister DNA strands. Damage of genetic material is known to interfere with essential cellular processes, such as transcription and DNA replication.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/dna-damage-response-targeting-therapeutics-market.html
    Despite of an exhaustive mechanism of DNA processing and its highly stable structure, DNA is bound to undergo damage by several factors DNA damage can be referred to as any adverse alteration, which may occur in the form of base additions, base deletions or break in the sister DNA strands. Damage of genetic material is known to interfere with essential cellular processes, such as transcription and DNA replication. For additional details, please visit https://www.rootsanalysis.com/reports/dna-damage-response-targeting-therapeutics-market.html
    DNA Damage Response Market | DDR Therapeutics | DDR Drugs Market | DNA Damage Response Drugs Market | Market Size | 2030
    With promising development pipeline and encouraging clinical trial results, DDR targeting therapeutics market is anticipated to reach over USD 1 billion by 2030
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030

    Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html
    The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2030 Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries For additional details, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html
    Blood-Brain Barrier (BBB) | Industry Analysis | Market Size | 2030
    Blood-Brain Barrier (BBB) Market, 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics Nanoparticle based Approaches)
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Telemedicine Tools and Software Providers Market

    The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market.html
    Telemedicine Tools and Software Providers Market The ability to remotely monitor patients using various consultation tools and software have revolutionized modern healthcare practices. For additional details, please visit https://www.rootsanalysis.com/reports/telemedicine-tools-and-software-providers-market.html
    Remote Patient Monitoring Market | Industry Analysis | Market Size | 2030
    Given their various benefits, the remote patient monitoring solution providers market is poised to grow at a CAGR of over 24.0%, till 2030...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion

    High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such molecules; the domain has witnessed an increased inflow of investments and collaboration opportunities.

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    Growing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such molecules; the domain has witnessed an increased inflow of investments and collaboration opportunities. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html
    Antibody Discovery: Services and Platforms Market (4rd Edition) | Industry Analysis | Market Size | 2030
    We anticipate the antibody discovery services and platforms market to grow at an annualized rate of over 23% in the coming decade; the opportunity is likely to be well-distributed across geographies
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

    In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved

    For additional details, please visit
    https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved For additional details, please visit https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    Avastin® (Bevacizumab) Biosimilars - Pipeline Review and Partnerships
    AvastinR (Bevacizumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7%

    Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic

    For additional details, please visit
    https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    The at-home blood collection and micro sampling devices market is anticipated to grow at an annualized rate of 10.7% Considering the cost saving potential associated with the use of at-home blood collection and micro sampling devices in diagnostics, the adoption of such products is anticipated to rise further, specifically amidst the COVID-19 pandemic For additional details, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html
    At-Home Blood Collection and Micro Sampling Devices Market | Industry Analysis | Market Size | 2030
    At-Home Blood Collection and Micro Sampling Devices Market report features an extensive study of the current market...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
  • The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years

    In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved

    For additional details, please visit
    https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    The Avastin® biosimilars market is projected to witness noteworthy growth over the coming years In 2020, revenues from the sales of Avastin®, Roche’s anti-VEGFA antibody based therapeutic, were observed to have declined by 25% due to competition from biosimilars, in the United States, Europe, Japan, and other nations where it is approved For additional details, please visit https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
    Avastin® (Bevacizumab) Biosimilars - Pipeline Review and Partnerships
    AvastinR (Bevacizumab) Biosimilars - Pipeline Review and Partnerships report features an extensive study of the current market landscape and future potential...
    WWW.ROOTSANALYSIS.COM
    0 Comments 0 Shares
More Stories